Secondary catabolic mucinosis of skin
MONDO:00216553 clinical trials for this condition and its sub-types, 0 tagged with Secondary catabolic mucinosis of skin itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Secondary catabolic mucinosis of skin
-
Folliculotropic mycosis fungoides 3 trials
-
New combo therapy hopes to tackle rare skin cancer
Disease control Recruiting nowThis phase II trial tests whether combining a targeted antibody drug (mogamulizumab) with a procedure that treats white blood cells with light (extracorporeal photopheresis) can better control erythrodermic cutaneous T-cell lymphoma, a rare skin cancer. About 34 adults with advan…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Immunotherapy and chemo join forces against tough lymphoma
Disease control Recruiting nowThis study tests two drugs—durvalumab (an immunotherapy) and lenalidomide (a chemotherapy drug)—alone or together in people with T-cell lymphoma that has returned or not responded to prior treatment. The goal is to find the best dose and see how well the combination works. About …
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC